A C-TERMINAL PRES1 SEQUENCE IS SUFFICIENT TO RETAIN HEPATITIS-B VIRUS L-PROTEIN IN 293 CELLS

被引:13
|
作者
GALLINA, A
GAZINA, E
MILANESI, G
机构
[1] CNR, IST GENET BIOCHIM & EVOLUZIONIST, I-27100 PAVIA, ITALY
[2] RUSSIAN ACAD MED SCI, DI IVANOVSKII VIROL INST, MOSCOW 123098, RUSSIA
关键词
D O I
10.1006/viro.1995.1546
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Analysis of deletion and/or site-specific mutants of the hepatitis B virus (HBV) env gene, expressed in human cells, provided clues about the mechanism that retains the L protein, the largest gene product, in a pre-Golgi compartment. Differences in secretability of the analyzed variants suggest that the N-terminal myristic acid and an internal sequence within the PreS1 region function as independent retention signals. N-terminal myristic acid alone neither prevented PreS1 + 2 N-linked glycosylation, which signals cotranslational translocation of the domain, nor strongly inhibited lumenal budding. Thus, myristic acid by itself acts by arresting secretion of lumenal, soluble Env particles. By contrast, the internal retention determinant, mapping in the C-terminal portion of PreS1, also prevented budding. In addition, the presence of this PreS1 segment correlated with the depression of PreS1 + 2 glycosylation. This suggests a connection between L retention and the recently described inhibition of PreS1 + 2 cotranslational translocation. A model can be proposed, according to which HBV surface proteins need to cotranslationally translocate their N-terminal moieties in order to assume a transmembrane topology suitable for particulate assembly and secretion. L protein, whose PreS1 + 2 domain undergoes translocation only posttranslationally, would fail to complete the secretion process. To support this model, we show that forced cotranslational translocation of the PreS1 + 2 domain (by attachment of an N-terminal processed signal sequence) results in secretion of L protein. (C) 1995 Academic Press, Inc.
引用
收藏
页码:57 / 69
页数:13
相关论文
共 50 条
  • [21] THE PRES1 DOMAIN OF HEPATITIS-B VIRUS AND IGA CROSS-REACT IN THEIR BINDING TO THE HEPATOCYTE SURFACE
    PONTISSO, P
    RUVOLETTO, MG
    TIRIBELLI, C
    GERLICH, WH
    RUOL, A
    ALBERTI, A
    JOURNAL OF GENERAL VIROLOGY, 1992, 73 : 2041 - 2045
  • [22] FINE SPECIFICITY OF THE HUMAN T-CELL RESPONSE TO THE HEPATITIS-B VIRUS PRES1 ANTIGEN
    FERRARI, C
    CAVALLI, A
    PENNA, A
    VALLI, A
    BERTOLETTI, A
    PEDRETTI, G
    PILLI, M
    VITALI, P
    NERI, TM
    GIUBERTI, T
    FIACCADORI, F
    GASTROENTEROLOGY, 1992, 103 (01) : 255 - 263
  • [23] RELATIONSHIP OF SERUM PRES1 ANTIGEN CONCENTRATION TO INFECTIVITY OF HEPATITIS-B VIRUS (HBV) CARRIER MOTHERS
    MIMMS, L
    WHITTERS, E
    KUHNS, M
    ROSENLOF, R
    TYNER, J
    LELIE, P
    IP, H
    WRAY, L
    EBLE, K
    HEPATOLOGY, 1988, 8 (05) : 1326 - 1326
  • [24] THE PRES1 ANTIGEN OF HEPATITIS-B VIRUS IS HIGHLY IMMUNOGENIC AT THE T-CELL LEVEL IN MAN
    FERRARI, C
    PENNA, A
    BERTOLETTI, A
    CAVALLI, A
    VALLI, A
    SCHIANCHI, C
    FIACCADORI, F
    JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (04): : 1314 - 1319
  • [25] HIGH-LEVEL EXPRESSION OF HEPATITIS-B VIRUS PRES1 PEPTIDE IN ESCHERICHIA-COLI
    RHYUM, SB
    JIN, BR
    PARK, HR
    HONG, HJ
    JOURNAL OF BIOTECHNOLOGY, 1994, 36 (03) : 221 - 230
  • [26] ANTIBODIES TO SYNTHETIC PEPTIDES FROM THE PRES1 REGION OF THE HEPATITIS-B VIRUS (HBV) ENVELOPE (ENV) PROTEIN ARE VIRUS-NEUTRALIZING AND PROTECTIVE
    NEURATH, AR
    SETO, B
    STRICK, N
    VACCINE, 1989, 7 (03) : 234 - 236
  • [27] ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS
    Mancin, Fabrizio
    Quarta, Santina
    Biasiolo, Alessandra
    Fabris, Enrica
    Guarino, Gaetano
    Ruvoletto, Mariagrazia
    Villano, Gianmarco
    Turato, Cristian
    Gatta, Angelo
    Scrimin, Paolo
    Pontisso, Patrizia
    HEPATOLOGY, 2011, 54 : 761A - 761A
  • [28] VARIABLE EXPRESSION OF PRES1 ANTIGEN IN SERUM DURING CHRONIC HEPATITIS-B VIRUS-INFECTION - AN ACCURATE MARKER FOR THE LEVEL OF HEPATITIS-B VIRUS-REPLICATION
    PETIT, MA
    ZOULIM, F
    CAPEL, F
    DUBANCHET, S
    DAUGUET, C
    TREPO, C
    HEPATOLOGY, 1990, 11 (05) : 809 - 814
  • [29] Processing of hepatitis C virus core protein is regulated by its C-terminal sequence
    Kato, T
    Miyamoto, M
    Furusaka, A
    Date, T
    Yasui, K
    Kato, J
    Matsushima, S
    Komatsu, T
    Wakita, T
    JOURNAL OF MEDICAL VIROLOGY, 2003, 69 (03) : 357 - 366
  • [30] An anti-viral peptide derived from the preS1 surface protein of hepatitis B virus
    Kim, Do-Hyoung
    Ni, Yi
    Lee, Si-Hyung
    Urban, Stephan
    Han, Kyou-Hoon
    BMB REPORTS, 2008, 41 (09) : 640 - 644